✦ LIBER ✦

Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma

✍ Scribed by Alan P. Venook

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 394 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21123

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting the epidermal growth factor re

Targeting the epidermal growth factor receptor by erlotinib (Tarceva™) for the treatment of esophageal cancer

✍ Andreas P. Sutter; Michael Höpfner; Alexander Huether; Kerstin Maaser; Hans Sche 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 370 KB 👁 1 views

## Abstract Esophageal cancer is the sixth most common cause of cancer‐related death worldwide. Because of very poor 5‐year survival new therapeutic approaches are mandatory. Erlotinib (Tarceva™), an inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR‐TK), potently suppresses the gr

Epidermal growth factor receptor targete

Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck

✍ Mark E. Sharafinski; Robert L. Ferris; Soldano Ferrone; Jennifer R. Grandis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR

Receptors for epidermal growth factor an

Receptors for epidermal growth factor and steroid hormones in primary colorectal tumors

✍ Giovanni Scambia; Pierluigi Benedetti Panici; Rocco Bellantone; Giovanni Battist 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

The presence of epidermal growth factor, estrogen, and progesterone receptors (EGFR, ER, and PR) was investigated by a competitive binding assay in 43 colorectal adenocarcinomas and 32 normal colorectal mucosa specimens. EGFR were expressed in most of the tumor specimens analyzed at levels comparabl

Anti-epidermal growth factor receptor-an

Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer

✍ Christine Solbach; Marc Roller; Andre Ahr; Sibylle Loibl; Maria Nicoletti; Manfr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 1 views

Recent studies demonstrated that tumors overexpressing the epidermal growth factor receptor (EGF-R, erbB-1) are associated with poor clinical outcome. This led to the development of a variety of monoclonal antibodies targeting the extracellular domain of this receptor tyrosine kinase. The aim of our

Comparison of two antibodies for immunoh

Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa

✍ Rohit Bhargava; Beiyun Chen; David S. Klimstra; Leonard B. Saltz; Cyrus Hedvat; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

Monoclonal antibodies to target epiderma

Monoclonal antibodies to target epidermal growth factor receptor–positive tumors : A new paradigm for cancer therapy

✍ Roy S. Herbst; Dong M. Shin 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB